Use of receptor and nonreceptor tyrosine kinase inhibitors and Parkinson disease risk

More on Parkinson's disease

• Sunitinib selectively killed senescent cells in the lab

  Biomedicine & Pharmacotherapy · 6 Oct 2026

  

• Dopamine loss in sleep disorder predicts Parkinson conversion

  Sleep Medicine · 4 Oct 2026

  

• Targeted nanoplatform reduces microglial senescence and eases motor deficits in Parkinson mice

  Advanced Science · 2 Oct 2026

• Sephin1 promotes mitophagy and reduces alpha-synuclein toxicity in Parkinson models

  Biochemical Pharmacology · 2 Oct 2026